Prostate cancer is far more prevalent than neuroendocrine tumors. The American Cancer Society estimates that there will be about 161,360 new cases of prostate cancer…
Read More
Despite technological advancements in the healthcare industry, breast cancer remains a major health problem. Self-examination and annual screening mammograms continue to be the most common methods used for early…
Screening frequency is being questioned; Innovations needed Questions around the rise in cancers in former Air Force pilots are causing concerns about the role of…
PARK CITY, Utah, August 13, 2019 /PRNewswire-PRWeb/ — The American Society of Breast Surgeons recently announced new cancer screening guidelines that are designed to help…
VPAC1 biomarkers are expressed on cell surfaces in high densities at the onset of oncogenesis. When VPAC1 receptors are targeted, cancer can be diagnosed early,…
NEW YORK (360Dx) — NuView Life Sciences has signed an agreement to evaluate its NV-VPAC1 urogenital cancer test on Aperture Bio’s screening platform, the company…
Current approaches to prostate cancer screening and diagnosis are plagued with limitations in diagnostic accuracy. There is a compelling need for biomolecular imaging that will…
A recent study validating urine diagnosis for cancer cell receptors in prostate cancer is eclipsing traditional methodology and warrants further steps toward FDA approval says…
The cancer (tumor) profiling market is expected to grow at a CAGR of 19.1% over the next four years. This growth directly reflects the public’s…
